NO962720L - Kappa-opiatagonister for inflammatoriske tarmsykdommer - Google Patents

Kappa-opiatagonister for inflammatoriske tarmsykdommer

Info

Publication number
NO962720L
NO962720L NO962720A NO962720A NO962720L NO 962720 L NO962720 L NO 962720L NO 962720 A NO962720 A NO 962720A NO 962720 A NO962720 A NO 962720A NO 962720 L NO962720 L NO 962720L
Authority
NO
Norway
Prior art keywords
inflammatory bowel
bowel disease
opiate agonists
kappa opiate
kappa
Prior art date
Application number
NO962720A
Other languages
English (en)
Other versions
NO962720D0 (no
NO309674B1 (no
Inventor
Andrew Barber
Christoph Seyfried
Gerd Bartoszyk
Rudolf Gottschlich
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO962720D0 publication Critical patent/NO962720D0/no
Publication of NO962720L publication Critical patent/NO962720L/no
Publication of NO309674B1 publication Critical patent/NO309674B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO962720A 1995-06-28 1996-06-27 Anvendelse av N-metyl-N-[(1S)-1-fenyl-2-((3S)-3- hydroksypyrrolidin-1-yl)-etyl]-2,2-difenylacetamid til fremstilling av legemiddelpreparater for behandling av inflammatoriske tarmsykdommer NO309674B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19523502A DE19523502A1 (de) 1995-06-28 1995-06-28 Kappa-Opiatagonisten für entzündliche Darmerkrankungen

Publications (3)

Publication Number Publication Date
NO962720D0 NO962720D0 (no) 1996-06-27
NO962720L true NO962720L (no) 1996-12-30
NO309674B1 NO309674B1 (no) 2001-03-12

Family

ID=7765475

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962720A NO309674B1 (no) 1995-06-28 1996-06-27 Anvendelse av N-metyl-N-[(1S)-1-fenyl-2-((3S)-3- hydroksypyrrolidin-1-yl)-etyl]-2,2-difenylacetamid til fremstilling av legemiddelpreparater for behandling av inflammatoriske tarmsykdommer

Country Status (26)

Country Link
US (2) US5776972A (no)
EP (1) EP0752246B1 (no)
JP (2) JP4415075B2 (no)
KR (1) KR100501612B1 (no)
CN (1) CN1119147C (no)
AR (1) AR004671A1 (no)
AT (1) ATE214275T1 (no)
AU (1) AU708699B2 (no)
BR (1) BR9602915A (no)
CA (1) CA2179955C (no)
CO (1) CO4700454A1 (no)
CZ (1) CZ289805B6 (no)
DE (2) DE19523502A1 (no)
DK (1) DK0752246T3 (no)
ES (1) ES2171577T3 (no)
HU (1) HU226976B1 (no)
NO (1) NO309674B1 (no)
PL (1) PL185537B1 (no)
PT (1) PT752246E (no)
RU (1) RU2190401C2 (no)
SI (1) SI0752246T1 (no)
SK (1) SK283497B6 (no)
TR (1) TR199600497A2 (no)
TW (1) TW430557B (no)
UA (1) UA51615C2 (no)
ZA (1) ZA965480B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US6303611B1 (en) * 1996-03-08 2001-10-16 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
JP4167302B2 (ja) * 1996-12-02 2008-10-15 杏林製薬株式会社 新規ｎ―置換ピロリジン誘導体及びその製造法
WO1998049141A1 (en) * 1997-04-30 1998-11-05 Warner-Lambert Company Kappa opioid agonists
CA2288828A1 (en) * 1997-07-14 1999-01-28 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
DE19827633A1 (de) * 1998-04-20 1999-10-21 Merck Patent Gmbh Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid
DE10116978A1 (de) * 2001-04-05 2002-10-10 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
EP2074997A1 (en) 2002-05-17 2009-07-01 Tioga Pharmaceuticals, Inc. Use of Asimadoline for the treatment of digestive disorders
AU2003269399A1 (en) * 2002-11-01 2004-05-25 Pfizer Products Inc. Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination
DE10259245A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh Derivate des Asimadolins mit kovalent gebundenen Säuren
EP1642590A4 (en) * 2003-07-04 2009-05-13 Santen Pharmaceutical Co Ltd MEANS TO INHIBIT THE DEGRADATION OF THE PAIN LIMIT
JP2007509865A (ja) * 2003-10-30 2007-04-19 ティオガ ファーマシュウティカルズ，インコーポレイテッド 神経障害の治療における選択的オピエート受容体調節物質の使用
US7160902B2 (en) * 2003-11-14 2007-01-09 Adolor Corporation Amide derivatives and methods of their use
US7642274B2 (en) 2004-07-02 2010-01-05 Santen Pharmaceutical Co., Ltd. Inhibitor of pain threshold decrease
EP2561870A1 (en) * 2007-03-30 2013-02-27 Tioga Pharmaceuticals, Inc. Kappa-Opiate Agonists For The Treatment Of Diarrhea-Predominant and Alternating Irritable Bowel Syndrome
DK2822928T3 (en) 2012-03-05 2019-03-11 Dr Reddys Laboratories Ltd SUBSTITUTED HETEROCYCLIC ACETAMIDS AS CAPE-OPIOID RECEPTOR (CHOR) AGONISTS
EP3097093A1 (en) * 2014-01-24 2016-11-30 Cadila Healthcare Limited Novel heterobicyclic compounds as kappa opioid agonists
EP3558300B1 (en) 2016-12-21 2021-11-24 Tioga Pharmaceuticals, Inc. Solid pharmaceutical formulations of asimadoline
WO2019122361A1 (en) 2017-12-22 2019-06-27 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Asimadoline for use in treating pulmonary diseases, vascular diseases, and sepsis
EP3932390A1 (en) 2020-07-02 2022-01-05 Dr. August Wolff GmbH & Co. KG Arzneimittel Topical gel formulation containing asimadoline

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663343A (en) * 1985-07-19 1987-05-05 Warner-Lambert Company Substituted naphthalenyloxy-1,2-diaminocyclohexyl amide compounds
DE4034785A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
US5232978A (en) * 1988-12-23 1993-08-03 Merck Patent Gesellschaft Mit Beschrankter Haftung 1-(2-arylethyl)-pyrrolidines
CA2021817C (en) * 1989-07-24 2000-09-26 William J. Mork Upholstered article of furniture with interchangeable seating module
DE4215213A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Arylacetamide

Also Published As

Publication number Publication date
TW430557B (en) 2001-04-21
HU226976B1 (en) 2010-04-28
JP2008201794A (ja) 2008-09-04
CN1145781A (zh) 1997-03-26
EP0752246A3 (de) 1997-02-26
AU5616296A (en) 1997-01-09
ES2171577T3 (es) 2002-09-16
ZA965480B (en) 1997-01-27
HUP9601798A1 (hu) 1998-03-30
KR970000230A (ko) 1997-01-21
SI0752246T1 (en) 2002-10-31
NO962720D0 (no) 1996-06-27
CA2179955A1 (en) 1996-12-29
KR100501612B1 (ko) 2005-10-12
TR199600497A2 (tr) 1997-01-21
SK84396A3 (en) 1997-04-09
BR9602915A (pt) 1998-04-22
US5776972A (en) 1998-07-07
CN1119147C (zh) 2003-08-27
CZ186696A3 (en) 1997-01-15
NO309674B1 (no) 2001-03-12
PL185537B1 (pl) 2003-05-30
DK0752246T3 (da) 2002-05-13
DE19523502A1 (de) 1997-01-02
EP0752246A2 (de) 1997-01-08
RU2190401C2 (ru) 2002-10-10
JPH0920659A (ja) 1997-01-21
US5977161A (en) 1999-11-02
ATE214275T1 (de) 2002-03-15
AU708699B2 (en) 1999-08-12
CZ289805B6 (cs) 2002-04-17
CA2179955C (en) 2008-10-07
DE59608861D1 (de) 2002-04-18
PT752246E (pt) 2002-09-30
SK283497B6 (sk) 2003-08-05
AR004671A1 (es) 1999-03-10
JP5308056B2 (ja) 2013-10-09
CO4700454A1 (es) 1998-12-29
JP4415075B2 (ja) 2010-02-17
UA51615C2 (uk) 2002-12-16
PL314996A1 (en) 1997-01-06
EP0752246B1 (de) 2002-03-13

Similar Documents

Publication Publication Date Title
NO962720D0 (no) Kappa-opiatagonister for inflammatoriske tarmsykdommer
NO974387L (no) Gjengeforbindelse for rör
NO961647D0 (no) Gjengeforbindelse for rör
NO981281D0 (no) Forbedringer vedrörende rörrensing
NO961887D0 (no) -adrenergiske agonister
DE69821817D1 (de) Photoinduzierte Entladung für Xerographie
DE69605623D1 (de) Mehrschichtrohr
BR9607235A (pt) Sulfonilaminocarboniltriazolinonas tendo substituintes de halogenoalquiltio
DE69611368D1 (de) Oligonukleotide spezifisch für humane papillomaviren
ID18917A (id) Proses untuk sintesis benzotiofena
DE59601221D1 (de) Langgestreckte rohrförmige Hülle
DE69634464D1 (de) Cachespeicher
FR2737755B3 (fr) Raccord perfectionne pour structures tubulaires
DE69613264D1 (de) Reinigungseinheit für Verzugszylinder
IS1809B (is) Kasttrekt fyrir fiskilínu
ID26842A (id) Proses untuk membuat klorobenzoksazola
KR970002339U (ko) 파이프용 분기관
KR960014992U (ko) 배수관용 나선형관
ID21349A (id) Proses untuk sintesis benzotiophena
AT1078U3 (de) Halterung für tuben
KR970006372U (ko) 배수로관
ID23162A (id) Proses untuk mendekomposisi sikloalkilhidroperoksida
KR970049204U (ko) 파이프 벤딩기
KR970060916U (ko) 소형파이프류의 굽힘기
KR970024447U (ko) 파이프 홀더